Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews


Clearbridge BioMedics announced that it has successfully registered its target cell enrichment device, the ClearCell FX1 system, with the U.S. Food and Drug Administration (FDA) as a Class I Medical Device, for in vitro diagnostic use. This registration marks a significant milestone in providing a reliable liquid biopsy solution for clinical research in the United States. The ClearCell FX1 system has also previously attained CE marking to be used as an in-vitro diagnostic medical device in Europe and China Food and Drug Administration-approved Class I Medical Device status via the company's MGI partnership.

Read more ...

Biocartis (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company, announced the signing of a new companion diagnostic (CDx) development agreement with Amgen, a leading biotechnology company, aimed at the development of Idylla™ CDx biomarker tests for a novel oncology compound to be used in the treatment of certain solid tumors.

Read more ...

Created by medical practitioners and the world’s foremost experts at the cutting edge of imaging technology, this two-day conference in central London addresses the need for an integrated approach to developing medical imaging systems for clinical use. The conference bridges the gap between medical professionals and the imaging technology supply chain, providing the community with a better understanding of the challenges and capabilities of today’s advanced medical imagers.

Read more ...

Alveo Technologies, a pre-clinical stage medical diagnostics firm, announced that it has raised $38 million in Series A financing. The Alameda, California-based startup, which was founded in 2014, said it plans to use the funding to advance the optimization and commercialization of its rapid diagnostic platform for infectious diseases. The firm's technology combines nucleic acid detection with molecular biochemistry in order to identify such illnesses.

Read more ...

Thermo Fisher Scientific announced the Ion GeneStudio S5 Series, a new line of bench top next-generation sequencing (NGS) instruments that provides unmatched flexibility and scalability enabled by five Ion S5 chips, including the new Ion 550 chip, to facilitate wide-ranging experiments on a single platform. The new series also provides low cost per sample for small and large projects across multiple research applications.

Read more ...

Significantly enhanced battery life for always-on devices.

Read more ...

Upcoming Events

> Medisens
(February 26 - February 27, London, UK)

> CRISPR & precision genome editing
(February 28 - February 28, Boston, USA)

> Medical Wearables 2018
(May 16 - May 17, Santa Clara, California)


No events


BioMEMS, the next big thing for MEMS players ?
Discover the presentation held by Sébastien Clerc at MEMS & Sensors Executive Congress, in ...
Status of the Microfluidics Industry
Discover the presentation held by Sébastien Clerc at Sensor China Conference of September 1...
Status of the Microfluidics Industry
Discover the presentation held by Benjamin Roussel at EAC Annual Conference 2017, in Singap...

Access to all our presentations